Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

HHS makes big vaccine purchase

November 27, 2006 | A version of this story appeared in Volume 84, Issue 48

The Department of Health & Human Services has awarded about $200 million in contracts to three companies for 5.3 million doses of vaccine designed to protect against the H5N1, or bird flu, influenza virus strain. The awards include $119.9 million to Sanofi Pasteur for 3.7 million doses; $41.0 million to Novartis for 800,000 doses; and $40.6 million to GlaxoSmithKline for 800,000 doses. HHS has an existing stockpile of 5.9 million doses. It wants to build a stockpile of 40 million doses, enough to vaccinate 20 million people.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.